Lahrtz patent opposition analysis

The comprehensive analysis of Lahrtz opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Lahrtz

Patent NumberTitleApplicantOpposition DateOpposition Company
Modulation Of Afucosylated Species In A Monoclonal Antibody CompositionOUTLOOK THERAPEUTICSApr 21, 2021PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB
Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding ReagentsBOEHRINGER INGELHEIMFeb 26, 2021CHUGAI SEIYAKU KABUSHIKI KAISHA
Method For Producing Acetic AcidDAICELAug 19, 2020CELANESE
Crispr-Based Genome Modification And RegulationSIGMA ALDRICHJul 9, 2020PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB
Vinyl Acetate-Ethylene / Acrylic Polymer Emulsions And Products And Methods Relating TheretoAVERY DENNISONOct 4, 2019CELANESE
Use Of Rank/Rankl Antagonists For Treating Neuromuscular Disorders, Genetic Myopathies And/Or Non Genetic Myopathies And/Or For Regulating Skeletal And Cardiac Muscle Disuse, Diseases And AgingUNIVERSIT LAVALJun 18, 2019PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB
Breast Cancer TherapeuticsIMBA INSTITUT FR MOLEKULARE BIOTECHNOLOGIEJan 28, 2019PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSNov 7, 2018MERUS
Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical ApplicationsGENETHONOct 10, 2018PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB